Results 131 to 140 of about 37,867 (253)

Molecular epidemiology of Clostridioides difficile in patients with inflammatory bowel disease in China [PDF]

, 2019
Tao� Lv, Yunbo Chen, Lisi Zheng, Tao Wu, Ping Shen, Lanjuan Li   +5 more
openalex   +1 more source

Risk of Acute Kidney Injury andClostridioides difficileInfection With Piperacillin/Tazobactam, Cefepime, and Meropenem With or Without Vancomycin [PDF]

, 2020
Jazmin D Lee, Brett H. Heintz, Hilary J. Mosher, Daniel J. Livorsi, Jason A. Egge, Brian C. Lund   +5 more
openalex   +1 more source

Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study [PDF]

Objectives The main aim of this study was to compare the clinical outcomes of patients attended in our area with Clostridioides difficile infection (CDI) (sustained cure, recurrence or death) in relation to treatment to normal or hypervirulent C ...
Cuadros González, Juan, Hernando Gozalo, Marcos, Pérez Tanoira, Ramón, Rescalvo Casas, Carlos, Seijas Pereda, Laura   +4 more
core   +1 more source

Economic burden attributable to Clostridioides difficile infections in South Korea: a nationwide propensity score-matched study

, 2021
Kang Ju Son, Y.A. Kim, Y.S. Park
openalex   +2 more sources

Wolf in Sheep’s Clothing: Clostridioides difficile Biofilm as a Reservoir for Recurrent Infections [PDF]

, 2021
Jazmín Meza‐Torres, Emile Auria, Bruno Dupuy, Yannick D. N. Tremblay   +3 more
openalex   +1 more source

The presence of Clostridioides difficile in faeces before and after faecal microbiota transplantation and its relation with recurrent C. difficile infection and the gut microbiota in a Dutch cohort [PDF]

Objectives: The objectives of this study are to investigate the presence of Clostridioides difficile in faeces of patients with recurrent C. difficile infection (rCDI) before and after faecal microbiota transplantation (FMT) and to identify risk factors ...
, Berssenbrugge, Eric K L, Ducarmon, Quinten R, Goorhuis, Abraham, Groenewegen, Bas, Keller, Josbert J, Kovynev, Artemiy, Kuijper, Ed J, Sanders, Ingrid M J G, Smits, Wiep Klaas, Terveer, Elisabeth M, van den Berg, Alexander J, van Lingen, Emilie, van Nood, Els, van Prehn, Joffrey, Wiese, Maria   +15 more
core   +1 more source

Characterisation and antibiotic susceptibility profile of Clostridioides (Clostridium) difficile isolated from chicken carcasses [PDF]

, 2020
Enver Barış Bingöl, Hamparsun Hampikyan, Karlo Muratoğlu, Esra Akkaya, Ömer Çetin, Hilal Çolak   +5 more
openalex   +1 more source

In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection [PDF]

, 2021
Nader S. Abutaleb, Mohamed N. Seleem
openalex   +1 more source

Contribution of MALDI‐TOF mass spectrometry and machine learning including deep learning techniques for the detection of virulence factors of Clostridioides difficile strains

Microbial Biotechnology
Clostridioides difficile (CD) infections are defined by toxins A (TcdA) and B (TcdB) along with the binary toxin (CDT). The emergence of the ‘hypervirulent’ (Hv) strain PR 027, along with PR 176 and 181, two decades ago, reshaped CD infection ...
Alexandre Godmer, Quentin Giai Gianetto, Killian Le Neindre, Valentine Latapy, Mathilda Bastide, Muriel Ehmig, Valérie Lalande, Nicolas Veziris, Alexandra Aubry, Frédéric Barbut, Catherine Eckert   +10 more
doaj   +1 more source

Management of Clostridioides difficile infection: an Italian Delphi consensus [PDF]

Background: Clostridioides difficile infection (CDI), a leading cause of nosocomial deaths, is a microbiota-mediated disease. As such, the use of broader spectrum antibiotics, such as vancomycin and metronidazole, can prime the gastrointestinal tract to ...
Armuzzi, Alessandro, Bassetti, Matteo, Caprioli, Flavio, Cascio, Antonio, De Rosa, Francesco Giuseppe, Dentali, Francesco, Meschiari, Marianna, Pani, Marcello, Parrella, Roberto, Petrosillo, Nicola, Pilotto, Alberto, Restelli, Umberto, Sanguinetti, Maurizio   +12 more
core   +2 more sources